Allan E. Wulc
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Allan E. Wulc has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Catherine J. Hwang
Orbital & Oculofacial Plastic Surgery, Department of Ophthalmology, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio, U.S.A.
3 shared publications Craig N. Czyz
3 shared publications- John Burroughs
Private Practice, Springs Aesthetics, Colorado Springs, Colorado
3 shared publications - Julie Woodward
Oculofacial Cosmetic and Reconstructive Surgery, Department of Ophthalmology, Duke University Medical Center, Durham, North Carolina, U.S.A.
3 shared publications Pooja Mally
3 shared publications- Daniel B. Rootman
Department of Ophthalmology, Orbital and Ophthalmic Plastic Surgery Division, University of California, Los Angeles, CA
2 shared publications
Latest Publications
- 4 November 2026
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 42 (6) , 734-736
Aesthetic Oculofacial Abstracts
Was not provided for this article.
- 4 November 2026
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 42 (6) , 734-736
Aesthetic Oculofacial Abstracts
Was not provided for this article.
- 8 September 2026
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 42 (5) , 612-614
Aesthetic Oculofacial Abstracts
Was not provided for this article.
- 8 September 2026
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 42 (5) , 612-614
Aesthetic Oculofacial Abstracts
Was not provided for this article.
- 4 November 2025
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 41 (6) , 730-732
Aesthetic Oculofacial Abstracts
Was not provided for this article.
- 4 November 2025
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 41 (6) , 730-732
Aesthetic Oculofacial Abstracts
Was not provided for this article.
- 24 April 2024
- Published by Elsevier in Advances in Cosmetic Surgery
- Vol. 7 (1)
Copyright
- 21 January 2024
- Published by Elsevier in Advances in Cosmetic Surgery
- Vol. 7 (1) , 135-149
Endoscopic Preperiosteal Midface Lift Revisited
- 21 January 2024
- Published by Elsevier in Advances in Cosmetic Surgery
- Vol. 7 (1) , 135-149
Endoscopic Preperiosteal Midface Lift Revisited
- 9 January 2024
- Published by Elsevier in Advances in Cosmetic Surgery
- Vol. 7 (1) , 119-123
Brow Lifts in Male Patients
- 9 January 2024
- Published by Elsevier in Advances in Cosmetic Surgery
- Vol. 7 (1) , 119-123
Brow Lifts in Male Patients
- 1 November 2019
- Published by SAGE Publications in JAMA Facial Plastic Surgery
- Vol. 21 (6) , 535-541
Investigation of the Longevity of the Endoscopic Midface Lift
Importance: To our knowledge, until now, the efficacy and durability of the transtemporal endoscopic preperiosteal midface lift has not been reported in the literature. Objective: To determine the efficacy and longevity of the endoscopic preperiosteal midface lift using objective measurements and validated aesthetic scales. Design, Setting, and Participants: This retrospective review included patients 18 years or older who were treated for aging midface by endoscopic midface lift by the senior author (A.E.W.) between June 2000 and August 2016. Patients were categorized based on length of follow-up into 3 groups: (1) short-term (1-3 years), (2) intermediate-term (3-5 years), and (3) long-term (>5 years). Interventions or Exposures: Endoscopic preperiosteal midface lift. Main Outcomes and Measures: (1) Objective measurements of midfacial height (the width of the interzygomatic distance of the midface to the medial canthus [WIZDOM-MC]), (2) validated regional aesthetic scales, and (3) global aesthetic scoring systems measured preoperatively, 3 to 6 months postoperatively, and at the most recent follow-up visit. Results: Adult patients 18 years or older (median [range] age, 59 [31-79] years) who were treated for aging midface by undergoing an endoscopic midface lift were included in this study. The medical records of 143 patients were reviewed (135 women and 8 men). The endoscopic midface lift resulted in objective improvement in midfacial height. The median WIZDOM-MC decreased by 3.4 mm after the endoscopic midface lift (interquartile range [IQR], 2.3-4.4 mm; P < .001), thus shortening the elongated lower eyelid. At 5 to 15 years after surgery, there was a sustained decrease in median WIZDOM-MC of 2.1 mm (IQR, 0.8-3.1 mm; P < .001). Improvement in the infraorbital hollow was also sustained in patients at more than 5 years’ follow-up (IQR, 0-1.0; P < .001). Improvements in upper cheek fullness and lower cheek fullness were maintained at 3 to 5 years and tended to be at baseline at more than 5 years. Global aesthetic improvement scores remained significantly improved at 5 to 15 years’ follow-up. Conclusions and Relevance: There is a significant, objective improvement in midfacial height after the endoscopic midface lift that persists for up to 15 years. Validated midfacial scales and global aesthetic scoring systems demonstrate sustained improvement in midface appearance over time. Surgery that minimally disrupts the zygomatic and orbicularis retaining ligaments can provide long-lasting aesthetic improvements. Level of Evidence: 4 .
- 1 November 2019
- Published by SAGE Publications in JAMA Facial Plastic Surgery
- Vol. 21 (6) , 535-541
Investigation of the Longevity of the Endoscopic Midface Lift
Importance: To our knowledge, until now, the efficacy and durability of the transtemporal endoscopic preperiosteal midface lift has not been reported in the literature. Objective: To determine the efficacy and longevity of the endoscopic preperiosteal midface lift using objective measurements and validated aesthetic scales. Design, Setting, and Participants: This retrospective review included patients 18 years or older who were treated for aging midface by endoscopic midface lift by the senior author (A.E.W.) between June 2000 and August 2016. Patients were categorized based on length of follow-up into 3 groups: (1) short-term (1-3 years), (2) intermediate-term (3-5 years), and (3) long-term (>5 years). Interventions or Exposures: Endoscopic preperiosteal midface lift. Main Outcomes and Measures: (1) Objective measurements of midfacial height (the width of the interzygomatic distance of the midface to the medial canthus [WIZDOM-MC]), (2) validated regional aesthetic scales, and (3) global aesthetic scoring systems measured preoperatively, 3 to 6 months postoperatively, and at the most recent follow-up visit. Results: Adult patients 18 years or older (median [range] age, 59 [31-79] years) who were treated for aging midface by undergoing an endoscopic midface lift were included in this study. The medical records of 143 patients were reviewed (135 women and 8 men). The endoscopic midface lift resulted in objective improvement in midfacial height. The median WIZDOM-MC decreased by 3.4 mm after the endoscopic midface lift (interquartile range [IQR], 2.3-4.4 mm; P < .001), thus shortening the elongated lower eyelid. At 5 to 15 years after surgery, there was a sustained decrease in median WIZDOM-MC of 2.1 mm (IQR, 0.8-3.1 mm; P < .001). Improvement in the infraorbital hollow was also sustained in patients at more than 5 years’ follow-up (IQR, 0-1.0; P < .001). Improvements in upper cheek fullness and lower cheek fullness were maintained at 3 to 5 years and tended to be at baseline at more than 5 years. Global aesthetic improvement scores remained significantly improved at 5 to 15 years’ follow-up. Conclusions and Relevance: There is a significant, objective improvement in midfacial height after the endoscopic midface lift that persists for up to 15 years. Validated midfacial scales and global aesthetic scoring systems demonstrate sustained improvement in midface appearance over time. Surgery that minimally disrupts the zygomatic and orbicularis retaining ligaments can provide long-lasting aesthetic improvements. Level of Evidence: 4 .
- 1 January 2019
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 35 (1) , 101-102
Reply Re: “Orbicularis Retaining Ligament Release in Lower Blepharoplasty: Assessing Efficacy and Complications”
- 1 January 2019
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 35 (1) , 101-102
Reply Re: “Orbicularis Retaining Ligament Release in Lower Blepharoplasty: Assessing Efficacy and Complications”
- 1 September 2016
- Published by Elsevier in Atlas of the Oral and Maxillofacial Surgery Clinics
- Vol. 24 (2) , 153-159
Management of Lower Eyelid Laxity
- 1 September 2016
- Published by Elsevier in Atlas of the Oral and Maxillofacial Surgery Clinics
- Vol. 24 (2) , 153-159
Management of Lower Eyelid Laxity
- Open Access
- 10 June 2015
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal
- Vol. 35 (5) , NP128
Response to “Comments on ‘The Role of Gravity in Periorbital and Midfacial Aging’”
We thank you for the opportunity to clarify a number of important points from our study.
- 10 June 2015
- Published by Oxford University Press (OUP) in Aesthetic Surgery Journal
- Vol. 35 (5) , NP128
Open AccessResponse to “Comments on ‘The Role of Gravity in Periorbital and Midfacial Aging’”
We thank you for the opportunity to clarify a number of important points from our study.